The company, which has been pushing its IPO plans for the past year, has been waiting to complete the integration of its acquired biosimilars firm Viatris and refinance debt before it goes public ...

Infinity Natural Resources Inc. priced its initial public offering above the midpoint of its range in a sign of a strong ...

Standing out in the B2B software market requires a combination of strong operating metrics, clear communication, robust reporting, and a well-defined exit strategy. By focusing on these essentials, ...

The company will finalise the IPO share allotment by February 3, and the trading in Malpani Pipes shares will commence on the ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

Global corporate investments in all forms of AI totalled $761 billion from 2021 to 2023. Services revenue (Apple Music, ...

During a panel discussion at this year’s Fierce JPM Week—which took place alongside the annual J.P. | This week on “The Top ...

Sebi is proposing a new combo product that pairs term life insurance with mutual fund investments, aiming to expand financial access and boost SIPs, particularly in rural areas.

The amount raised via IPOs almost tripled from ₹53,023 crore to ₹1.53 trillion in the same period. The mainboard platform ...

Dr Agarwal's Healthcare will utilise ₹195 crore out of the net fresh issue proceeds for repaying its debt, and the remaining ...

Several major companies, across various sectors are gearing up for their IPOs, aiming to capitalize on the growing investor ...